无固醇抗胰岛素 (NSAID) 降低子宫内装置期间疼痛的有效性 插入:系统性审查
Isabella Martingano1, Emma Lakey1, David Raskin2
1Medical Student, Tilman J. Fertitta Family College of Medicine, University of Houston, Houston, TX, USA.
概括
非类固醇抗炎药物 (NSAIDs) 在将子宫内装置 (IUD) 插入时减轻疼痛方面表现出有限的有效性. 大多数研究没有发现任何显著的益处,强调需要更好的疼痛管理策略.
科学领域:
- 生殖健康 生殖健康
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 宫内器械 (IUD) 是一种高效的避孕药.
- 插入疼痛是许多寻求IUD的重要障碍.
- 目前的建议通常包括非类固醇抗炎药 (NSAIDs),但证据有限.
结论:
- 预防性NSAIDs在缓解IUD插入疼痛方面表现出有限的有效性,70%的研究报告没有显著的益处.
- 研究结果表明,它的有效性低于以前的假设,因此需要标准化止痛方法.
- 不同类型的NSAID使用和疼痛评估需要有针对性的研究来增强以患者为中心的护理.
相关概念视频
Local Anesthetics: Clinical Application as Epidural Anesthesia
1.0K
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
1.0K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
Intrauterine Drug Delivery Systems
168
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
168


